Isabell Seitz-Merwald, Ph. D.
Head of QM & QA / Leitung QM & QS at GBA Group Pharma & Medical Devices- Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Gold Feature
Click to upgrade to our gold package
for the full feature experience.
Location
Greater Munich Metropolitan Area, DE
Languages
-
Englisch -
-
Französisch -
Topline Score
Topline score feature will be out soon.
Bio
Generated by
Topline AI
You need to have a working account to view this content.
Join now
You need to have a working account to view this content.
Join now
Experience
-
GBA Group Pharma & Medical Devices
-
Germany
-
Public Health
-
1 - 100 Employee
-
Head of QM & QA / Leitung QM & QS
-
Jun 2023 - Present
-
-
-
Juno Therapeutics, Inc.
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Associate Director Analytical Development and Quality Control
-
Oct 2020 - May 2023
-
-
-
Neovii
-
Switzerland
-
Biotechnology
-
1 - 100 Employee
-
Head Of Quality Control / Leitung Qualitätskontrolle
-
Oct 2016 - Sep 2020
-
-
Senior Manager Quality Control
-
Apr 2011 - Sep 2016
Transplantation, Antibodies, Immunology, Analytical method validation
-
-
Manager Preclinical Research and Development
-
Jul 2010 - Mar 2011
Transplantation, Antibodies, Immunology
-
-
Manager Research and Development
-
Apr 2007 - Jun 2010
Oncology, Transplantation, Antibodies, Immunology
-
-
-
Deutsches Herzzentrum München des Freistaates Bayern - Klinik an der Technischen Universität München
-
Germany
-
Hospitals and Health Care
-
200 - 300 Employee
-
Post Doc
-
Jun 2006 - Mar 2007
Inflammation, atherogenesis
-
-
PhD Student
-
May 2002 - May 2006
Inflammation, atherogenesis
-
-
-
Elegene AG
-
Martinsried
-
Research Scientist
-
Sep 2000 - May 2002
Neurodegenerative diseases Neurodegenerative diseases
-
-
Education
-
Ludwig-Maximilians Universität München
Diplom, Biologie, allgemein -
Technische Universität München
Vordiplom, Biologie, allgemein
Community
You need to have a working account to view this content.
Click here to join now